Skip to main content

Animations

MJFF Publications

1931 - 1940 of 6431 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2024.101669
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Nova-ST: Nano-patterned ultra-dense platform for spatial transcriptomics
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100831
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Interpretable discriminant analysis for functional data supported on random nonlinear domains with an application to Alzheimer’s disease
    Journal Name: Journal of the Royal Statistical Society Series B: Statistical Methodology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/jrsssb/qkae023
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patterns
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae286
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD
    Journal Name: Frontiers in Digital Health
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-240035
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230446
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A multi-region single nucleus transcriptomic atlas of Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-024-04117-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
    Journal Name: BMC Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s12916-024-03766-5
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A call for clinical trial globalization in Alzheimer's disease and related dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12995
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.